USAQ (QHSLab) Valuation Rank


USAQ QHSLab Inc USAQ
47 GF Score
Price $0.27
GF Value $0.19
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is QHSLab Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

QHSLab Valuation Rank Related Terms

USAQ
47GF Score
QHSLab Inc USAQ
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is QHSLab (USAQ) Overvalued in 2026?

Based on GuruFocus' analysis, QHSLab stock appears to be overvalued. The current stock price of $0.27 is trading 39.5% above its estimated GF Value™ of $0.19. GuruFocus considers QHSLab to be Significantly Overvalued.

Key valuation signals for USAQ:

  • Valuation Rank:
  • GF Value™: $0.19 vs. price of $0.27 (39.5% above fair value)
  • GF Score™: 47/100 with 3 warning signs

No single metric tells the full story. See the USAQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

QHSLab Business Description

Address 901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. The company is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
47GF Score

Get the complete analysis for USAQ

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.27
Price
$0.19
GF Value